Bjorn Eliasson
0000-0003-2569-4160
117 papers found
Refreshing results…
Level of physical activity associated with risk of cardiovascular diseases and mortality in patients with type-2 diabetes: report from the Swedish National Diabetes Register
Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: A nationwide observational study from the Swedish National Diabetes Register
LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes
Towards Renewed Health Economic Simulation of Type 2 Diabetes: Risk Equations for First and Second Cardiovascular Events from Swedish Register Data
Ongoing treatment with renin-angiotensin-aldosterone-blocking agents does not predict normoalbuminuric renal impairment in a general type 2 diabetes population
[Risk factors for cardiovascular disease. Results from the Swedish national diabetes register compared with international studies]
Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register
Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes : an observational study from the Swedish National Diabetes Register
HbA1C and Cancer Risk in Patients with Type 2 Diabetes – A Nationwide Population-Based Prospective Cohort Study in Sweden
Long-term mortality in patients with type 2 diabetes undergoing coronary angiography: The impact of glucose-lowering treatment
The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: An observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes
Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: An observational study from the Swedish national diabetes register
The Size of Large Adipose Cells Is a Predictor of Insulin Resistance in First-Degree Relatives of Type 2 Diabetic Patients
Lowering of postprandial lipids in individuals with type 2 diabetes treated with alogliptin and/or pioglitazone: A randomised double-blind placebo-controlled study
Increased Urine IgM and IgG2Levels, Indicating Decreased Glomerular Size Selectivity, Are Not Affected by Dalteparin Therapy in Patients with Type 2 Diabetes
Different methods to present the effect of blood pressure on cardiovascular diseases by Cox regression:
Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: A cohort study from the Swedish National Diabetes Register
Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation
A new model for 5-year risk of cardiovascular disease in Type 1 diabetes; from the Swedish National Diabetes Register (NDR): Cardiovascular disease risk prediction in Type 1 diabetes
A new model for 5-year risk of cardiovascular disease in type 2 diabetes, from the Swedish National Diabetes Register (NDR)
Missing publications? Search for publications with a matching author name.